AAAAAA

   
Results: 1-8 |
Results: 8
N-linked oligosaccharides of cobra venom factor contain novel alpha(1-3)galactosylated Le(x) structures
Authors: Gowda, DC Glushka, J van Halbeek, H Thotakura, RN Bredehorst, R Vogel, CW
Citation: Dc. Gowda et al., N-linked oligosaccharides of cobra venom factor contain novel alpha(1-3)galactosylated Le(x) structures, GLYCOBIOLOG, 11(3), 2001, pp. 195-208
Structural studies on the cobra venom factor: isolation, purification, crystallization and preliminary crystallographic analysis
Authors: Sharma, S Jabeen, T Singh, RK Bredhorst, R Vogel, CW Betzel, C Singh, TP
Citation: S. Sharma et al., Structural studies on the cobra venom factor: isolation, purification, crystallization and preliminary crystallographic analysis, ACT CRYST D, 57, 2001, pp. 596-598
Initial characterization of the apoptosis-inducing receptor for natural human anti-neuroblastoma IgM
Authors: David, K Heiligtag, S Ollert, MW Teppke, M Vogel, CW Bredehorst, R
Citation: K. David et al., Initial characterization of the apoptosis-inducing receptor for natural human anti-neuroblastoma IgM, MED PED ONC, 36(1), 2001, pp. 251-257
Serotype distribution and secretory acid proteinase activity of Candida albicans isolated from the oral mucosa of patients with denture stomatitis
Authors: McMullan-Vogel, CG Jude, HD Ollert, MW Vogel, CW
Citation: Cg. Mcmullan-vogel et al., Serotype distribution and secretory acid proteinase activity of Candida albicans isolated from the oral mucosa of patients with denture stomatitis, ORAL MICROB, 14(3), 1999, pp. 183-189
Effect of complement consumption by cobra venom factor on the course of primary infection with simian immunodeficiency virus in rhesus monkeys
Authors: Schmitz, JE Lifton, MA Reimann, KA Montefiori, DC Shen, L Racz, P Tenner-Racz, K Ollert, MW Forman, MA Gelman, RS Vogel, CW Letvin, NL
Citation: Je. Schmitz et al., Effect of complement consumption by cobra venom factor on the course of primary infection with simian immunodeficiency virus in rhesus monkeys, AIDS RES H, 15(2), 1999, pp. 195-202
Natural human IgM antibodies in neuroblastoma therapy: Preliminary resultsfrom a phase I/II therapy study
Authors: Schmitt, C David, K Hiller, J Schrum, J Bredehorst, R Vogel, CW Loliger, C Erttmann, R
Citation: C. Schmitt et al., Natural human IgM antibodies in neuroblastoma therapy: Preliminary resultsfrom a phase I/II therapy study, KLIN PADIAT, 211(4), 1999, pp. 314-318
Human natural immunoglobulin M antibodies induce apoptosis of human neuroblastoma cells by binding to a M-r 260,000 antigen
Authors: David, K Ollert, MW Vollmert, C Heiligtag, S Eickhoff, B Erttmann, R Bredehorst, R Vogel, CW
Citation: K. David et al., Human natural immunoglobulin M antibodies induce apoptosis of human neuroblastoma cells by binding to a M-r 260,000 antigen, CANCER RES, 59(15), 1999, pp. 3768-3775
A nonhuman primate model for the selective elimination of CD8+lymphocytes using a mouse-human chimeric monoclonal antibody
Authors: Schmitz, JE Simon, MA Kuroda, MJ Lifton, MA Ollert, MW Vogel, CW Racz, P Tenner-Racz, K Scallon, BJ Dalesandro, M Ghrayeb, J Rieber, EP Sasseville, VG Reimann, KA
Citation: Je. Schmitz et al., A nonhuman primate model for the selective elimination of CD8+lymphocytes using a mouse-human chimeric monoclonal antibody, AM J PATH, 154(6), 1999, pp. 1923-1932
Risultati: 1-8 |